lung cancer leading cause of cancer death
Two Phase 3 Trials Of Sunitinib With Commonly Used Chemotherapies In Advanced Breast Cancer Did Not Meet The Primary …
NEW YORK—-Pfizer Inc. announced today that two Phase 3 studies of Sutent® in advanced breast cancer did not meet their primary endpoints. The SUN 1064 Phase 3 study of sunitinib in combination with docetaxel for the first-line treatment of patients with advanced HER-2 negative breast cancer did not show a statistically significant improvement in progression-free survival compared with …
Marijuana Two Minute Truths Doesn’t Cause Lung Cancer
